Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

Share

March 2022; 9 (2) ArticleOpen Access

Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway

Ruo-Song Ai, Kun Xing, Xin Deng, Juan-Juan Han, Dong-Xia Hao, Wen-Hui Qi, Bing Han, Ya-Na Yang, Xing Li, View ORCID ProfileYuan Zhang
First published February 1, 2022, DOI: https://doi.org/10.1212/NXI.0000000000001142
Ruo-Song Ai
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a2s@snnu.edu.cn
Kun Xing
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xkkkobe@snnu.edu.cn
Xin Deng
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xindeng@snnu.edu.cn
Juan-Juan Han
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jjhan_jn@163.com
Dong-Xia Hao
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: haodongxia@snnu.edu.cn
Wen-Hui Qi
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wenhui-q@snnu.edu.cn
Bing Han
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: binghan_snnu@snnu.edu.cn
Ya-Na Yang
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yyn03082865@snnu.edu.cn
Xing Li
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lixing@snnu.edu.cn
Yuan Zhang
From the Shaanxi Normal University, Xi'an, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yuan Zhang
Full PDF
Citation
Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway
Ruo-Song Ai, Kun Xing, Xin Deng, Juan-Juan Han, Dong-Xia Hao, Wen-Hui Qi, Bing Han, Ya-Na Yang, Xing Li, Yuan Zhang
Neurol Neuroimmunol Neuroinflamm Mar 2022, 9 (2) e1142; DOI: 10.1212/NXI.0000000000001142

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
642

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1 BA Enhances CNS Myelinogenesis During Postnatal Development

    (A) Treatment paradigms. (B) Representative sections stained for Olig2, NG2, APC, and DAPI of spinal cord segment harvested on postnatal day 14 (Scale bar = 50 μm). Quantifications were performed by counting the Olig2, NG2, and APC positive nucleated cells at random areas. (C) Ventral roots of peripheral motor nerve at the level of the lumbar spinal cord segment and corpus callosum harvested on postnatal day 14 were stained for myelin with antibodies to MBP and for axonal fibers with antibodies for neurofilament H (Scale bar, 50 μm). MBP intensity was measured in the ventral roots of spinal cord or corpus callosum using Image-Pro. (D.a-c) D.a: Beam walking test was performed on postnatal day 18, and the latency to traverse each beam and the time the hind feet slip off each beam are recorded for each trial. D.b: The wire hang test was performed on postnatal day 19. Mice received 2 consecutive trials, and the latency to traverse the beam was recorded for each trial (cutoff time 60 seconds). D.c: The rotarod test was performed on postnatal day 21, and the latency to fall off the rod and the actual rotating speed level was measured. The average latency of falling off the rod and the average actual rotating speed was recorded. Data of (B, C, D) are shown as mean values ±SEM and analyzed by 2-tailed Student t-test (n = 5 each group). *p < 0.05, **p < 0.01, and ***p < 0.001. BA = baicalin.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2 BA Enhances Remyelination in CPZ-Induced Demyelination Model

    (A) A schematic drawing of demyelination/remyelination mice model. Male, 8- to 10-wk-old C57BL/6 mice were fed with cuprizone for 6 weeks to achieve complete demyelination, followed by feeding normal chow in another 2 weeks. Mice were randomly divided into normal chow + PBS groups (NC, n = 6 and PBS-treated groups (CPZ + PBS, n = 12) and BA-treated (CPZ + BA, n = 12), all groups receive BA or PBS treatment starting at CPZ model beginning until the 6 + 3 weeks. A schematic diagram of corpus callosum lateral to lateral ventricle and location observed by paraffin section staining (LFB). (B) LFB and FluoroMyelin staining at different time point (Scale bar, 200 μm). Slices were assessed and scored in a blinded fashion for demyelination: 3, large (confluent); 2, a few areas of demyelination; 1, rare foci; 0, none. The quantification of the mean density of FluoroMyelin staining was performed using ImageJ. (C) Representative electron micrographs at 6 + 2 weeks (Scale bar, 2 μm for the upper row, and 1 μm for the insets in the lower row, rad arrows indicate typical myelin structure in each group). (D) The quantification of myelin G-ratio value (axon diameter/fiber diameter) of NC, CPZ + PBS, and CPZ + BA group. Scatter plot of G-ratio value. Data are shown as mean values ±SEM (n = 6 each group). *p < 0.05, **p < 0.01, and ***p < 0.001 compared with control group, one-way analysis of variance with Tukey multiple comparisons test. BA = baicalin; NC = naïve chow; PBS = phosphate-buffered saline.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3 Effect of BA Treatment on Astrocyte, Microglia, and Oligodendrocyte Precursor Cell Differentiation in CPZ-Induced Demyelination Model

    CPZ mice were treated with BA or PBS as shown in Figure 2A. (A) Double immunostaining of Olig2 (red) and APC (green). Scale bar, 100 μm for the upper row, and 50 μm for the insets in the lower row. The quantification of Olig2 positive cells and quantification analysis of the percentage of APC positive cells and Olig2 positive cells measured at random areas using Image-Pro. Date are mean ± SEM (n = 3 each group). (B) GFAP (green) immunostaining at corpus callosum section of all group mice at 6 + 2 weeks (Scale bar, 100 μm). The mean of GFAP-positive cell density was measured in corpus callosum using ImageJ. Data are mean ± SEM (n = 3 each group). (C.a-c) Behavioral assessment (beam walking test (C.a), wire hang test (C.b), and rotating rod test (C.c) of CPZ-induced demyelination mice. (D) The expression of cytokine genes was determined using real-time RT-PCR analysis at CPZ-induced 5 weeks. The expression of myelin-associated protein genes and neurotrophic factors was determined using real-time RT-PCR analysis at CPZ-induced 6 + 1 week. Data are shown as mean values ±SEM (n = 6 each group). *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control group, one-way analysis of variance with Tukey multiple comparisons test. BA = baicalin; CPZ = cuprizone.

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4 BA Directly Induced OPC Differentiation via PPARγ Signaling

    (A) Three-dimensional structure diagram of PPARγ docked with BA. (B) MST affinity determination of BA and PPARγ. (C) HEK293T cells were transfected with PPRE×3-TK-luciferase vector, a PPRE-dependent luciferase reporter constructs. After 24 hours of transfection, cells were cultured with BA of 10 μg/mL for 6 hours, and the activity of luciferase was monitored in cell lysates by a ONE-Glo EX Luciferase Assay System kit (Promega). (D) BA enhanced oligodendrocyte differentiation in primary OPC cultures. Primary OPCs, prepared from brains of newborn C57BL/6 mice, were cultured in the differentiation medium with or without BA (1, 5, or 10 μg/mL) for 5 days, followed by MBP immunofluorescence staining. Primary OPCs were cultured in a differentiation medium with BA (10 μg/mL) alone or pretreated for 30 minutes with GW-9662 (PPARγ-specific antagonist) before addition of BA or GW-9662 (10 nM) alone for 5 days, followed by MBP immunofluorescence staining. Nuclei were stained with DAPI (blue). Scale bar, 50 μm. A quantitative analysis was performed for numbers of MBP+ mature oligodendrocytes. Data are shown as mean values ± SEM and analyzed by two-tailed Student t-test (n = 5 each group). *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control group. BA = baicalin; MBP = myelin basic protein; OPC = oligodendrocyte precursor cell; PPARγ = peroxisome proliferator-activated receptor γ; PPRE = peroxisome proliferator element.

  • Figure 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5 Therapeutic Effects of BA on Demyelination Is Peroxisome Proliferator-Activated Receptor γ-Dependent

    CPZ mice were treated with BA or PBS as shown in Figure 3A. (A) Representative of Luxol fast blue stain. Scale bar, 100 μm. (B) Pathology score of demyelination at 3 weeks and 6 + 1 week (C) GFAP (green) and IBA1 (red) immunostaining at corpus callosum section of all group mice at 6 + 1 week. Scale bar, 50 μm. (D) The mean of GFAP or IBA1 positive cells density was measured in corpus callosum using ImageJ. Data are mean ± SEM (n = 3 each group). *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control group, one-way analysis of variance with Tukey multiple comparisons test. BA = baicalin; GFAP = glial fibrillary acidic protein; PBS = phosphate-buffered saline.

Tables

  • Figures
  • Table
  • links.lww.com/NXI/A691

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Study Funding
    • Disclosure
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Preferences and User Experiences of Wearable Devices in Epilepsy A Systematic Review and Mixed-Methods Synthesis

Dr. Daniel Friedman and Dr. Sharon Chiang

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Demyelinating disease (CNS)

Alert Me

  • Alert me when eletters are published
Neurology - Neuroimmunology Neuroinflammation: 10 (2)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Neuroimmunology & Neuroinflammation
Online ISSN: 2332-7812

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise